Neuroendocrine tumors: A registry of 1000 patients

Revista da Associacao Medica Brasileira

Volumn 54, Issue 4, 2008, Pages 305-307

  Younes, Riad Naim ^a,b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b NONE   (Brazil)

Author keywords

Carcinoid; Neuroendocrine tumor

Indexed keywords

ARTICLE; BRAZIL; CLINICAL TRIAL; DIGESTIVE SYSTEM TUMOR; FOLLOW UP; GASTROINTESTINAL TUMOR; HUMAN; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATHOLOGY; REGISTER; SURVIVAL RATE;

BRAZIL; DIGESTIVE SYSTEM NEOPLASMS; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; REGISTRIES; SURVIVAL RATE;

EID: 50249118635     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302008000400014     Document Type: Article

References (12)

1. Robertson RG, Geiger WJ, Davis NB. Carcinoid tumors. Am Fam Physician. 2006;74:429-34.
2. Pearson CM, Patrick J. Fitzgerald: Carcinoid tumors: a re-emphasis of their malignant nature. Review of 140 cases. Cancer. 2006;2:1005-26.
3. Warner RRP. A review of carcinoid cancer. The Carcinoid Cancer Foundation [cited 2007 Jan]. Available from: http://carcionoid.org.
4. Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist. 2005;10:123-31.
5. Ezziddin S, Logvifnski T, Yong-Hing C, Ahmadzadehfar H, Fisher H-P, Palmedo H, et al. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2006;47:223-336.
6. Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C. 68 Ga-DOTA-Tyr3-Octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508-18.
7. Rea F, Rizzardi G, Zuin A, Marulli G, Nicotra S, Bulf R, Schiavon M, Sartori F.: Outcome and surgical strategy in bronchial carcinoid tumors: single institution. Eur J Cardiothorac Surg. 2007;31:186-91.
8. Chong S, Lee KS, Kim BT, Choi JY, Yi CA, Chung MJ, Oh D, Lee JY: Integrated PET/CT of Pulmonary Neuroendocrine Tumors: Diagnostic and Prognostic Implications. AJR Am J Roentgenol. 2007;188:1223-31.
9. Ono K, Suzuki T, Miki Y, Taniyama Y, Nakamura Y, Noda Y, Watanabe M, Sasano H Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727. Anticancer Res. 2007;27:2231-9.
10. Fazio N, Braud F, Delle Fave G, Oberg K. Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?. Ann Oncol Adv. 2007;18:13-19.
11. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-59.
12. Younes RN. Tumores neuroendócrinos. In: Younes RN, editor. Tumores neuroendócrinos: recomendações baseadas em evidência. São Paulo: MBC; 2005. p.12-6.